Cancer Commons 100,000 lives can be saved every year
Retevmo (selpercatinib, formerly known as LOXO-292) (pronounced reh-TEHV-moh) is a selective and potent RET kinase inhibitor. Retevmo may have an effect on both tumor cells and wholesome cells, which may end up…
Read More